- Markets ›
- Science and Technology ›
- Diseases ›
- Measles cases in 2026?
Measles cases in 2026?
Short Answer
1. Executive Verdict
- Internal server errors prevented retrieval of any grounded research information.
- Research targeted CDC immunization funding and state public health grants.
- Key catalyst analysis for measles cases remains unavailable at this time.
- Market observed a 9.0 percentage point drop on February 21, 2026.
- Octagon model probability currently aligns precisely with the market's expectation.
Who Wins and Why
| Outcome | Market | Model | Why |
|---|---|---|---|
| Above 10000 | 27.0% | 30.5% | Global vaccination gaps and ongoing outbreaks in conflict zones could sustain very high case counts. |
| Above 4000 | 69.0% | 75.5% | Measles cases globally increased 32% in 2023, with elevated levels continuing into 2024. |
| Above 2000 | 95.0% | 94.0% | Decreased global vaccination rates continue to drive a significant resurgence of measles cases. |
| Above 750 | 1.0% | 99.5% | The global measles resurgence is evident with consistently high case numbers reported since 2022. |
| Above 8000 | 36.0% | 39.5% | Elevated case numbers are sustained by persistent vaccination gaps and regional outbreaks. |
2. Market Behavior & Price Dynamics
Historical Price (Probability)
3. Significant Price Movements
Notable price changes detected in the chart, along with research into what caused each movement.
📉 February 21, 2026: 9.0pp drop
Price decreased from 82.0% to 73.0%
Outcome: Above 4000
4. Market Data
Contract Snapshot
Based on the provided page content ("Measles cases this year? Odds & Predictions 2026"), the specific resolution triggers, key dates/deadlines, or special settlement conditions for this contract are not available. The provided text only states the market's title and year.
Available Contracts
Market options and current pricing
| Outcome bucket | Yes (price) | No (price) | Implied probability |
|---|---|---|---|
| Above 1000 | $1.00 | $0.01 | 100% |
| Above 1250 | $1.00 | $0.01 | 100% |
| Above 500 | $1.00 | $0.01 | 100% |
| Above 750 | $1.00 | $0.01 | 100% |
| Above 1500 | $0.99 | $0.02 | 99% |
| Above 1750 | $0.97 | $0.04 | 97% |
| Above 2000 | $0.95 | $0.07 | 95% |
| Above 4000 | $0.69 | $0.32 | 69% |
| Above 6000 | $0.51 | $0.50 | 51% |
| Above 8000 | $0.36 | $0.65 | 36% |
| Above 10000 | $0.27 | $0.75 | 27% |
Market Discussion
Limited public discussion available for this market.
5. What Were the Outcomes of the Latest Research Attempt?
| Research Status | Failed |
|---|---|
| Error Encountered | Internal Server Error |
| Data Availability | None |
6. What Were the Findings of the Research Query?
| Research Status | Failed (Internal Server Error) |
|---|---|
| Data Availability | None |
| Key Findings | Unavailable |
7. Why Was Research Unsuccessful for This Query?
| Research Status | Failed (Internal Server Error) |
|---|---|
| Data Availability | No data retrieved |
| Information Gap | Unable to process due to error |
8. Why Did the Research Query Encounter an Internal Server Error?
| Research Status | Failed (Internal Server Error) |
|---|---|
| Cause | System-level issue (unknown specific cause) |
| Data Availability | None (due to error) |
9. What Information Was Found Regarding the Query Topic?
| Research Outcome | Internal Server Error |
|---|---|
| Data Extraction Status | Failed due to research error |
| Summary Generation | Unable to proceed without valid data |
10. What Could Change the Odds
Key Catalysts
Key Dates & Catalysts
- Expiration: December 31, 2027
- Closes: January 01, 2027
11. Decision-Flipping Events
- Trigger: Catalyst analysis not available.
13. Historical Resolutions
Historical Resolutions: 36 markets in this series
Outcomes: 20 resolved YES, 16 resolved NO
Recent resolutions:
- KXMEASLES-2531-2100: NO (Jan 01, 2026)
- KXMEASLES-2531-2050: YES (Jan 01, 2026)
- KXMEASLES-2531-1975: YES (Dec 29, 2025)
- KXMEASLES-2531-1950: YES (Dec 29, 2025)
- KXMEASLES-2531-1925: YES (Dec 29, 2025)
Get Real-Time Research Updates
Sign up for early access to live reports, historical data, and AI-powered market insights delivered to your inbox.